Cohens Inhibitor-insensitive p38 Mutants

In the following paragraph, we describe the development of the technology, based on its first example, the kinase p38a. 

This was the first time that a drug-insensitive protein kinase was used for the purpose of drug target validation. Eyers et al. also discussed the general applicability to the study of other protein kinases [50], as is described in the next section. 

---